TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Hans Lennernäs Biomedical AB
Closing information (x1000 NOK)
| Closing information | 2023/06 | 2022/06 | 2021/06 |
| Turnover |
756
|
486 | |
| Financial expenses |
413
|
4 | |
| Earnings before taxes |
67
|
-91 | |
| EBITDA |
469
|
-111 | |
| Total assets |
14,683
|
15,362 | |
| Current assets |
907
|
702 | |
| Current liabilities |
263
|
166 | |
| Equity capital |
14,304
|
15,061 | |
| - share capital |
97
|
101 | |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/06 | 2022/06 | 2021/06 |
| Solvency |
97.4%
|
98.0% | |
| Turnover per employee |
756
|
486 | |
| Profit as a percentage of turnover |
8.9%
|
-18.7% | |
| Return on assets (ROA) |
3.3%
|
-0.6% | |
| Current ratio |
344.9%
|
422.9% | |
| Return on equity (ROE) |
0.5%
|
-0.6% | |
| Change turnover |
288
|
-121 | |
| Change turnover % |
62%
|
61%
|
-20% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/06 | 2022/06 | 2021/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.